Search Abstracts
Program

Session 46   Poster Session
Immunology: Miscellaneous
4:30-6:30 pm
4E-F

Click on the to view the poster for an abstract.


263-T.
PET-Detected Lymph Node Activation Correlates with Viremia
S. Iyengar, B. Chin, B. Sabundayo, J. Margolick, and D. Schwartz*
Johns Hopkins Univ., Baltimore, MD
Add to Itinerary
264-T. Predictors of Disease Progression among LTNP: A 5-Year Follow-Up Study
E. Vicenzi1, S. Ghezzi1, G. Vallanti1, F. Neri1, D. Douek2, E. Santagostino3, A. Gringeri3, M. Cusini3, G. Morsica1, A. Lazzarin1, F. Veglia3, and G. Poli*1
1San Raffaele Sci. Inst., Milano, Italy; 2NIAID, NIH, Bethesda, MD; and 3IRCCS Maggiore Hosp., Milano, Italy
Add to Itinerary
265-T.
Immunologic Marker Analysis in Real-Time (iMART): Usefulness of Immunophenotypic Markers in Predicting Immunologic and Virologic Outcomes in Ongoing ACTG Trials
D. Mildvan*1, R. J. Bosch2, R. Kim2, D. W. Haas3, J. Spritzler2, D. Kuritzkes4, M. Nokta5, A. Landay6, D. Livnat7, V. DeGruttola2, M. Moreno8, and J. Kagan7
1Beth Israel Med. Ctr., New York, NY; 2SDAC, Harvard Sch. of Publ. Hlth., Boston, MA; 3Vanderbilt Univ., Nashville, TN; 4Univ. of Colorado, Hlth. Sci. Ctr., Denver; 5Univ. of Texas, Galveston; 6Rush Presbyterian Med. Ctr., Chicago, IL; 7NIAID, NIH, Bethesda, MD; and 8Social and Scientific Systems, Rockville, MD
Add to Itinerary
266-T.
Differential Modulation of T Cells and APC by Low-Level Viral Replication under HAART in Chronically HIV-1-Infected Patients
E. C. Moore1, E. Papasavvas*1, J. Sun1, K. Mounzer3, J. Shull3, J. Kostman2, 3, and L. J. Montaner1
1Wistar Inst., Philadelphia, PA; 2Univ. of Pennsylvania, Philadelphia; and 3Philadelphia FIGHT, PA
Add to Itinerary
267-T. Plasma Levels of B-Lymphocyte Stimulator (BLyS) TM Protein Increase with HIV Disease Progression
B. Rodríguez*1, H. Valdez1, W. Freimuth2, T. Butler2, R. Asaad1, and M. Lederman1
1Case Western Reserve Univ. and Univ. Hosp. of Cleveland, OH and 2Human Genome Sci., Rockville, MD
Add to Itinerary
268-T. Prognostic Value of Immunologic and Virologic Markers in Late-Stage HIV-1 Disease: Data from HAVACS
J. L. Guest1,2, S. A. Stolfus2, and D. Rimland*1
1Atlanta VA Med. Ctr., Decatur, GA and 2Emory Univ., Atlanta, GA.
Add to Itinerary
269-T. Productive HIV Infection of CD4+ T Cells Lacking Markers of Classic T-Cell Activation: The Role of the Lymphoid Tissue Microenvironment
A. Kinter*, A. Moorthy, R. Jackson, and A. S. Fauci
NIAID, NIH, Bethesda, MD
Add to Itinerary
270-T. HIV-1 Infection Alters the Host's Cell Cycle and Transcription Machinery to Allow High HIV-1 Transcription and Efficient Viral Assembly and Dissemination
J. Yang*, M. Bosche, J. W. Adelsberger, T. Imamichi, C. Watkins, C. Yeager, D. Hosack, G. Dennis, B. Sherman, A. Rupert, R. Stevens, M. W. Baseler, and R. A. Lempicki
SAIC, Frederick, MD
Add to Itinerary
271-T. Activated CD4dimCD8bright T Cells Produce IL-4, Are Infected by HIV, and Can Be Detected in Vivo in HIV+ Patients
Y. B. Sullivan*, A. Landay, and L. Al-Harthi
Rush-Presbyterian St. Luke's Med. Ctr., Rush Univ., Chicago, IL
Add to Itinerary
272-T.
T-Cell Receptor-Mediated HIV-1 LTR Activation is Strongly Up-Regulated upon CD43 Cross-Linking: Involvement of NFAT and NFkappaB.
C. Barat, J. Roy*, and M. J. Tremblay
Laval Univ., Ste-Foy, QC, Canada
Add to Itinerary
273-T. IL-7 Induces HIV Productive Infection of Naďve T Cells: Impact on HIV Pathogenesis in the Naďve T-Cell Compartment
E. Z. Managlia*, C. M. Steffens, A. Landay, and L. Al-Harthi
Rush-Presbyterian St. Luke's Med. Ctr., Rush Univ., Chicago, IL
Add to Itinerary
274-T.
The Pro-Inflammatory Myeloid-Related Proteins Activate HIV Replication in Infected T Lymphocytes
C. Ryckman*, R. Cantin, G. A. Robichaud, M. J. Tremblay, and P. A. Tessier
Infectious Disease Res. Ctr., QC, Canada
Add to Itinerary
275-T. Binding of LFA-1 (CD11a) to ICAM-3 (CD50) and ICAM-2 (CD102) Triggers Transmigration of HIV-1-Infected Monocytes through Mucosal Epithelial Cells
M-P. Carreno*, N. Chomont, M. D. Kazatchkine, T. Irinopoulou, C. Krieff, A. Si-Mohamed, and L. Belec
(INSERM) Hosp. Broussais and Univ. Pierre et Marie Curie, Paris, France
Add to Itinerary
276-T.
Suppression of Interleukin (IL)-12 p40 Transcription by Acute HIV Infection: Disruption of Nuclear Factor Binding and Inhibition of MAP Kinase Activation
K. A. Chambers* and J. B. Angel
Ottawa Health Res. Inst., Univ. of Ottawa, ON, Canada
Add to Itinerary
277-T.
Differential Effects of IL-7 and IL-15 on Cytolytic Activity in Natural Killer Cells from HIV+ Patients
J. Lum*1, G. Mbisa1, D. H. Lynch2, Z. Nie1, N. Hawley-Foss1, and A. D. Badley1
1Ottawa Hlth. Res. Inst., ON, Canada and 2Immunex Corp., Seattle, WA
Add to Itinerary
278-T.
Cytoplasmic p21 WAF1/Cip1 Protects CD4 T Cells from HIV Mediated Apoptosis
T. Gomez*, R. Ricardo, C. Holz-Heppelmann, A. Villasis-Keever, S. Vlahakis, and C. V. Paya
Mayo Clin., Rochester, MN
Add to Itinerary
279-T.
Interleukin-7 Receptor (CD127) Expression and RNA Accumulation in CD8+ T Cells Is Down-Regulated by TNFalpha
A. Komsic* and J. B. Angel
Ottawa Hlth. Res. Inst., Univ. of Ottawa, ON, Canada
Add to Itinerary
280-T. Comparison of Multiple Analytical Methods to Measure Cytokine Production from Single T Cells
R. P. Bucy*1, G. Marshall1, P. Goepfert1, J. Jacobson2, and J. M. Kilby1
1Univ. of Alabama, Birmingham; and 2Mount Sinai Med. Ctr., New York, NY
Add to Itinerary
281-T.
In Vitro Derived Dendritic Cells Express Native HIV-1 Clade C gag Gene after Infection with a Recombinant Adenoviral Vector
D. Perumal*1, T. Papagatsias2, M. Roberts2, T. Athanasopoulos2, C. Gray3, G. Dickson2, F. Gotch1, and S. Patterson1
1Imperial Coll. Sch. of Sci., Technology and Med., London, UK and 2Royal Holloway Coll., Univ. of London, UK; and 3Natl. Inst. of Virology, Johannesburg, South Africa
Add to Itinerary
282-T.
Protease Inhibitors Reduce Apoptosis through a Mechanism which Is Independent of Caspase Inhibition
B. N. Phenix*, J. Lum, Z. Nie, J. Sanchez-Dardon, and A. D. Badley
Ottawa Hlth. Res. Inst., ON, Canada
Add to Itinerary
283-T.
Vitamin A, Pneumonia, HIV Infection, and Type-1 Cytokine Immunity
J. Jason*1, L. K. Archibald1, O. C. Nwanyanwu1, A. L. Sowell1, I. Buchanan1, J. Larned1, M. Bell1, P. N. Kazembe2, H. Dobbie2, and W. R. Jarvis1
1CDC, Atlanta, GA and 2Lilongwe Central Hosp. and the Community Hlth. Sci. Unit, Ministry of Hlth. and Population, Lilongwe, Malawi
Add to Itinerary
284-T.
Human Infection with Simian Foamy Viruses: Preliminary Results from an Immunologic Study
T. J. Spira*, L. Lam, R. S. Boneva, W. M. Switzer, J. M. Cummins, W. Heneine, T. M. Folks, and L. E. Chapman
CDC, Atlanta, GA
Add to Itinerary